Biomea Fusion (BMEA) announced the presentation of ... and potential as a combination therapy with GLP-1-based medicines. ATTD 2025 Conference Highlights: First Large-Scale Analysis of C-Peptide ...

Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $-0.24. Operator: Welcome to the Rani ...

PG-102 is ProGen’s Fc-fusion protein conjugated GLP-1/GLP-2 dual agonist. delivered via the RaniPill capsule. ProGen recently announced preliminary results of the repeat-dose portion of its ...

Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic ...

RT-114 combines ProGen's FC fusion protein conjugated GLP-1/GLP-2 dual agonist PG-102 with the RaniPill. The rationale behind this strategic partnership is to combine a potential best-in-class GLP ...

America’s colleges and universities enrich everyone in ways that aren’t often acknowledged. It’s high time to remind Americans of them.

RT-114 combines ProGen's FC fusion protein conjugated GLP-1/GLP-2 dual agonist PG-102 with the RaniPill. The rationale behind this strategic partnership is to combine a potential best in class GLP ...

Victoza, produced by Novo Nordisk, holds FDA approval for regulating blood sugar levels among individuals diagnosed with type ...

Fusion foods and multi-cuisine cooking is on the rise ... In stark contrast to number 4, the weight-loss trend is back and it’s bigger than ever. The rise of GLP-1 drugs and myriad new diets, has ...

1 This generation loves trying global cuisines and fusion dishes. They’re exploring ... For example, individuals using GLP-1 medications for weight loss are often choosing high-protein foods ...

SAN DIEGO — Results presented here showed the use of an allograft, autograft or no biologic adjuvant had equivalent fusion rates and ... SAN DIEGO — GLP-1 agonists may lead to increased ...